NEW YORK, May 31 – Motorola has decided to abandon its previously announced plans to exclusively license Molecular Staging’s rolling circle amplification technology for use in its diagnostic nucleic acid bioarrays, a spokeswoman for Molecular Staging said Thursday.

“Motorola does not have an exclusive license to the technology,” a spokeswoman for Molecular Staging said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.